Miltirone attenuates post-ischemic stroke neuroinflammation and microglial lipid metabolism via regulating LBP and

Gui-Xian Cai1, Kai-Kai Guo2

  • 1Department of Anesthesiology, The PLA Rocket Force Characteristic Medical Center, Beijing 100088, China.

Abstract

Insights

Miltirone, a compound from Salvia miltiorrhiza, offers neuroprotection against ischemic stroke by reducing inflammation, regulating lipid metabolism, and combating oxidative stress. This multi-target approach shows promise for clinical translation in stroke therapy.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Ischemic stroke is a primary cause of neurological disability with complex pathologies.
  • Current treatments are insufficient for multifactorial stroke damage.
  • Miltirone, from Salvia miltiorrhiza, exhibits antioxidant and anti-inflammatory properties, but its stroke-related neuroprotective mechanisms are unknown.

Purpose of the Study:

  • To investigate the neuroprotective mechanisms of Miltirone in ischemic stroke.
  • To evaluate Miltirone's effects on microglial polarization, lipid metabolism, and oxidative stress in stroke models.
  • To elucidate the molecular pathways targeted by Miltirone in stroke.

Main Methods:

  • Utilized young/aged distal Middle Cerebral Artery Occlusion (dMCAO) mouse models and oxygen-glucose deprivation/reperfusion (OGD/R) treated BV2 microglia.
  • Assessed infarct volume, neurological function, microglial polarization (M1/M2), cytokine levels, lipid metabolism, oxidative stress markers (ROS, SOD, MDA), and the TLR4/MyD88/NF-κB pathway.
  • Quantified outcomes using TTC staining, neurological tests, ELISA, immunofluorescence, RT-qPCR, Western blot, and flow cytometry.

Main Results:

  • Miltirone significantly reduced infarct volume and brain edema, improving neurological and motor recovery in dMCAO mice.
  • Miltirone promoted M2 microglial polarization, suppressed pro-inflammatory cytokines, and elevated anti-inflammatory cytokines.
  • Miltirone restored lipid homeostasis, inhibited lipid synthesis, activated lipolysis, reduced oxidative stress, and suppressed the LBP/TLR4/MyD88/NF-κB pathway.

Conclusions:

  • Miltirone demonstrates significant neuroprotection in ischemic stroke via multi-target actions.
  • It effectively modulates neuroinflammation, lipid metabolism, and oxidative stress through the LBP/TLR4/NF-κB axis.
  • Miltirone's comprehensive therapeutic potential makes it a promising candidate for clinical application in stroke treatment.

Related Concept Videos